Eterna Therapeutics
ERNA
£1.34
Share price
-5.79%
Change (1 day)
-4.94%
Change (1 year)
Categories
Eterna Therapeutics (ERNA) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : £8.24 Million
According to Eterna Therapeutics's latest financial reports the company's total liabilities are £8.24 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Eterna Therapeutics - Total liabilities on balance sheet (from 2020 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | £2.84 M | -92.28% |
| 2023-12-31 | £36.81 M | 337.83% |
| 2022-12-31 | £8.4 M | 88.5% |
| 2021-12-31 | £4.46 M | 15.88% |
| 2020-12-31 | £3.84 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | £10.67 B | 129,339.55% | 🇺🇸 USA |
 Geron GERN | £0.22 B | 2,572.47% | 🇺🇸 USA |
 Omeros Corporation OMER | £0.33 B | 3,975.88% | 🇺🇸 USA |
 Sanofi SNY | £46.56 B | 564,714.24% | 🇫🇷 France |
 Bio-Techne TECH | £0.46 B | 5,588.38% | 🇺🇸 USA |
 Genetic Technologies GENE | £2.18 M | -73.52% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | £24.07 B | 291,897.46% | 🇮🇱 Israel |